NFJ Investment Group LLC Makes New $1.69 Million Investment in Surgery Partners, Inc. (NASDAQ:SGRY)

NFJ Investment Group LLC bought a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 52,368 shares of the company's stock, valued at approximately $1,688,000.

Several other institutional investors also recently modified their holdings of the stock. Royce & Associates LP grew its position in Surgery Partners by 12.2% during the 3rd quarter. Royce & Associates LP now owns 510,261 shares of the company's stock worth $16,451,000 after acquiring an additional 55,545 shares during the last quarter. Lombard Odier Asset Management Europe Ltd bought a new stake in shares of Surgery Partners during the second quarter worth about $4,163,000. Rhumbline Advisers grew its holdings in shares of Surgery Partners by 19.6% during the second quarter. Rhumbline Advisers now owns 127,952 shares of the company's stock worth $3,044,000 after purchasing an additional 20,963 shares during the last quarter. Point72 Asset Management L.P. bought a new position in Surgery Partners in the 2nd quarter valued at approximately $29,288,000. Finally, Principal Financial Group Inc. bought a new position in Surgery Partners in the 3rd quarter valued at approximately $1,469,000.

Surgery Partners Trading Down 4.7 %

Shares of Surgery Partners stock traded down $1.06 on Thursday, hitting $21.46. 1,872,364 shares of the company's stock traded hands, compared to its average volume of 979,662. The company has a fifty day moving average of $28.20 and a two-hundred day moving average of $28.12. Surgery Partners, Inc. has a one year low of $21.10 and a one year high of $36.92. The company has a market capitalization of $2.73 billion, a price-to-earnings ratio of -44.71, a price-to-earnings-growth ratio of 19.15 and a beta of 2.58. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners's quarterly revenue was up 14.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.15 earnings per share. As a group, sell-side analysts expect that Surgery Partners, Inc. will post 0.73 earnings per share for the current year.

Wall Street Analysts Forecast Growth

SGRY has been the subject of several recent research reports. Cantor Fitzgerald restated an "overweight" rating and issued a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. UBS Group began coverage on shares of Surgery Partners in a research note on Monday, October 14th. They issued a "buy" rating and a $38.00 price objective on the stock. JPMorgan Chase & Co. cut their target price on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a report on Tuesday. Royal Bank of Canada decreased their price target on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a research note on Wednesday, November 20th. Finally, KeyCorp began coverage on Surgery Partners in a research note on Friday, October 11th. They issued a "sector weight" rating on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Surgery Partners presently has a consensus rating of "Moderate Buy" and a consensus target price of $37.38.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.